Sun Pharmaceutical Industries

The respective product approval is based on Revlimid Capsules, 5 mg, 10 mg, 15 mg, 25 mg and 2.5 mg, 20 mg as a reference product

The new agreement includes Japan, Australia, New Zealand, Brazil, Mexico and Russia

As a special tribute, announces various initiatives for the welfare of doctors, their families and the community

As per the directive of the SEC of the CDSCO, Dr Reddy’s will conduct the clinical trial and the other four pharma companies will…

CARITEC is an obstetric drug to prevent post-partum hemorrhage

The agreements have been signed with Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical…

New website highlights efficacy and safety profile for each product, educates healthcare providers and patients about intent to…

Brivaracetam is an anti-epileptic drug (AEDs) with fast onset of action and promising efficacy

It examines the role played and impact created by IPA member companies through CSR

ILUMYA is approved for adults with moderate-to-severe plaque psoriasis and is being evaluated for other possible uses